1 Study Coverage 1.1 Emerging Cancer Vaccines Product Introduction 1.2 Market by Type 1.2.1 Global Emerging Cancer Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Non Genetic Vaccines 1.2.3 Genetic Vaccines 1.3 Market by Application 1.3.1 Global Emerging Cancer Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Cancer Research Centers 1.3.3 Cancer Hospital 1.3.4 Clinics 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Emerging Cancer Vaccines Sales Estimates and Forecasts 2017-2028 2.2 Global Emerging Cancer Vaccines Revenue Estimates and Forecasts 2017-2028 2.3 Global Emerging Cancer Vaccines Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Emerging Cancer Vaccines Sales by Region 2.4.1 Global Emerging Cancer Vaccines Sales by Region (2017-2022) 2.4.2 Global Sales Emerging Cancer Vaccines by Region (2023-2028) 2.5 Global Emerging Cancer Vaccines Revenue by Region 2.5.1 Global Emerging Cancer Vaccines Revenue by Region (2017-2022) 2.5.2 Global Emerging Cancer Vaccines Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Emerging Cancer Vaccines Sales by Manufacturers 3.1.1 Global Top Emerging Cancer Vaccines Manufacturers by Sales (2017-2022) 3.1.2 Global Emerging Cancer Vaccines Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Emerging Cancer Vaccines in 2021 3.2 Global Emerging Cancer Vaccines Revenue by Manufacturers 3.2.1 Global Emerging Cancer Vaccines Revenue by Manufacturers (2017-2022) 3.2.2 Global Emerging Cancer Vaccines Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Emerging Cancer Vaccines Revenue in 2021 3.3 Global Emerging Cancer Vaccines Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Emerging Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Emerging Cancer Vaccines Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Emerging Cancer Vaccines Sales by Type 4.1.1 Global Emerging Cancer Vaccines Historical Sales by Type (2017-2022) 4.1.2 Global Emerging Cancer Vaccines Forecasted Sales by Type (2023-2028) 4.1.3 Global Emerging Cancer Vaccines Sales Market Share by Type (2017-2028) 4.2 Global Emerging Cancer Vaccines Revenue by Type 4.2.1 Global Emerging Cancer Vaccines Historical Revenue by Type (2017-2022) 4.2.2 Global Emerging Cancer Vaccines Forecasted Revenue by Type (2023-2028) 4.2.3 Global Emerging Cancer Vaccines Revenue Market Share by Type (2017-2028) 4.3 Global Emerging Cancer Vaccines Price by Type 4.3.1 Global Emerging Cancer Vaccines Price by Type (2017-2022) 4.3.2 Global Emerging Cancer Vaccines Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Emerging Cancer Vaccines Sales by Application 5.1.1 Global Emerging Cancer Vaccines Historical Sales by Application (2017-2022) 5.1.2 Global Emerging Cancer Vaccines Forecasted Sales by Application (2023-2028) 5.1.3 Global Emerging Cancer Vaccines Sales Market Share by Application (2017-2028) 5.2 Global Emerging Cancer Vaccines Revenue by Application 5.2.1 Global Emerging Cancer Vaccines Historical Revenue by Application (2017-2022) 5.2.2 Global Emerging Cancer Vaccines Forecasted Revenue by Application (2023-2028) 5.2.3 Global Emerging Cancer Vaccines Revenue Market Share by Application (2017-2028) 5.3 Global Emerging Cancer Vaccines Price by Application 5.3.1 Global Emerging Cancer Vaccines Price by Application (2017-2022) 5.3.2 Global Emerging Cancer Vaccines Price Forecast by Application (2023-2028) 6 North America 6.1 North America Emerging Cancer Vaccines Market Size by Type 6.1.1 North America Emerging Cancer Vaccines Sales by Type (2017-2028) 6.1.2 North America Emerging Cancer Vaccines Revenue by Type (2017-2028) 6.2 North America Emerging Cancer Vaccines Market Size by Application 6.2.1 North America Emerging Cancer Vaccines Sales by Application (2017-2028) 6.2.2 North America Emerging Cancer Vaccines Revenue by Application (2017-2028) 6.3 North America Emerging Cancer Vaccines Market Size by Country 6.3.1 North America Emerging Cancer Vaccines Sales by Country (2017-2028) 6.3.2 North America Emerging Cancer Vaccines Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Emerging Cancer Vaccines Market Size by Type 7.1.1 Europe Emerging Cancer Vaccines Sales by Type (2017-2028) 7.1.2 Europe Emerging Cancer Vaccines Revenue by Type (2017-2028) 7.2 Europe Emerging Cancer Vaccines Market Size by Application 7.2.1 Europe Emerging Cancer Vaccines Sales by Application (2017-2028) 7.2.2 Europe Emerging Cancer Vaccines Revenue by Application (2017-2028) 7.3 Europe Emerging Cancer Vaccines Market Size by Country 7.3.1 Europe Emerging Cancer Vaccines Sales by Country (2017-2028) 7.3.2 Europe Emerging Cancer Vaccines Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Emerging Cancer Vaccines Market Size by Type 8.1.1 Asia Pacific Emerging Cancer Vaccines Sales by Type (2017-2028) 8.1.2 Asia Pacific Emerging Cancer Vaccines Revenue by Type (2017-2028) 8.2 Asia Pacific Emerging Cancer Vaccines Market Size by Application 8.2.1 Asia Pacific Emerging Cancer Vaccines Sales by Application (2017-2028) 8.2.2 Asia Pacific Emerging Cancer Vaccines Revenue by Application (2017-2028) 8.3 Asia Pacific Emerging Cancer Vaccines Market Size by Region 8.3.1 Asia Pacific Emerging Cancer Vaccines Sales by Region (2017-2028) 8.3.2 Asia Pacific Emerging Cancer Vaccines Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Emerging Cancer Vaccines Market Size by Type 9.1.1 Latin America Emerging Cancer Vaccines Sales by Type (2017-2028) 9.1.2 Latin America Emerging Cancer Vaccines Revenue by Type (2017-2028) 9.2 Latin America Emerging Cancer Vaccines Market Size by Application 9.2.1 Latin America Emerging Cancer Vaccines Sales by Application (2017-2028) 9.2.2 Latin America Emerging Cancer Vaccines Revenue by Application (2017-2028) 9.3 Latin America Emerging Cancer Vaccines Market Size by Country 9.3.1 Latin America Emerging Cancer Vaccines Sales by Country (2017-2028) 9.3.2 Latin America Emerging Cancer Vaccines Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Emerging Cancer Vaccines Market Size by Type 10.1.1 Middle East and Africa Emerging Cancer Vaccines Sales by Type (2017-2028) 10.1.2 Middle East and Africa Emerging Cancer Vaccines Revenue by Type (2017-2028) 10.2 Middle East and Africa Emerging Cancer Vaccines Market Size by Application 10.2.1 Middle East and Africa Emerging Cancer Vaccines Sales by Application (2017-2028) 10.2.2 Middle East and Africa Emerging Cancer Vaccines Revenue by Application (2017-2028) 10.3 Middle East and Africa Emerging Cancer Vaccines Market Size by Country 10.3.1 Middle East and Africa Emerging Cancer Vaccines Sales by Country (2017-2028) 10.3.2 Middle East and Africa Emerging Cancer Vaccines Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Antigenics 11.1.1 Antigenics Corporation Information 11.1.2 Antigenics Overview 11.1.3 Antigenics Emerging Cancer Vaccines Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Antigenics Emerging Cancer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Antigenics Recent Developments 11.2 Avax Technologies 11.2.1 Avax Technologies Corporation Information 11.2.2 Avax Technologies Overview 11.2.3 Avax Technologies Emerging Cancer Vaccines Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Avax Technologies Emerging Cancer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Avax Technologies Recent Developments 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Corporation Information 11.3.2 GlaxoSmithKline Overview 11.3.3 GlaxoSmithKline Emerging Cancer Vaccines Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 GlaxoSmithKline Emerging Cancer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 GlaxoSmithKline Recent Developments 11.4 Merck 11.4.1 Merck Corporation Information 11.4.2 Merck Overview 11.4.3 Merck Emerging Cancer Vaccines Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Merck Emerging Cancer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Merck Recent Developments 11.5 Moderna 11.5.1 Moderna Corporation Information 11.5.2 Moderna Overview 11.5.3 Moderna Emerging Cancer Vaccines Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Moderna Emerging Cancer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Moderna Recent Developments 11.6 Northwest Biotherapeutics 11.6.1 Northwest Biotherapeutics Corporation Information 11.6.2 Northwest Biotherapeutics Overview 11.6.3 Northwest Biotherapeutics Emerging Cancer Vaccines Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Northwest Biotherapeutics Emerging Cancer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Northwest Biotherapeutics Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Emerging Cancer Vaccines Industry Chain Analysis 12.2 Emerging Cancer Vaccines Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Emerging Cancer Vaccines Production Mode & Process 12.4 Emerging Cancer Vaccines Sales and Marketing 12.4.1 Emerging Cancer Vaccines Sales Channels 12.4.2 Emerging Cancer Vaccines Distributors 12.5 Emerging Cancer Vaccines Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Emerging Cancer Vaccines Industry Trends 13.2 Emerging Cancer Vaccines Market Drivers 13.3 Emerging Cancer Vaccines Market Challenges 13.4 Emerging Cancer Vaccines Market Restraints 14 Key Findings in The Global Emerging Cancer Vaccines Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Emerging Cancer Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Non Genetic Vaccines Table 3. Major Manufacturers of Genetic Vaccines Table 4. Global Emerging Cancer Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 5. Global Emerging Cancer Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Emerging Cancer Vaccines Sales by Region (2017-2022) & (K Units) Table 7. Global Emerging Cancer Vaccines Sales Market Share by Region (2017-2022) Table 8. Global Emerging Cancer Vaccines Sales by Region (2023-2028) & (K Units) Table 9. Global Emerging Cancer Vaccines Sales Market Share by Region (2023-2028) Table 10. Global Emerging Cancer Vaccines Revenue by Region (2017-2022) & (US$ Million) Table 11. Global Emerging Cancer Vaccines Revenue Market Share by Region (2017-2022) Table 12. Global Emerging Cancer Vaccines Revenue by Region (2023-2028) & (US$ Million) Table 13. Global Emerging Cancer Vaccines Revenue Market Share by Region (2023-2028) Table 14. Global Emerging Cancer Vaccines Sales by Manufacturers (2017-2022) & (K Units) Table 15. Global Emerging Cancer Vaccines Sales Share by Manufacturers (2017-2022) Table 16. Global Emerging Cancer Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million) Table 17. Global Emerging Cancer Vaccines Revenue Share by Manufacturers (2017-2022) Table 18. Emerging Cancer Vaccines Price by Manufacturers (2017-2022) &(USD/Unit) Table 19. Global Emerging Cancer Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global Emerging Cancer Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emerging Cancer Vaccines as of 2021) Table 21. Emerging Cancer Vaccines Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Emerging Cancer Vaccines Product Offered Table 23. Date of Manufacturers Enter into Emerging Cancer Vaccines Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Emerging Cancer Vaccines Sales by Type (2017-2022) & (K Units) Table 26. Global Emerging Cancer Vaccines Sales by Type (2023-2028) & (K Units) Table 27. Global Emerging Cancer Vaccines Sales Share by Type (2017-2022) Table 28. Global Emerging Cancer Vaccines Sales Share by Type (2023-2028) Table 29. Global Emerging Cancer Vaccines Revenue by Type (2017-2022) & (US$ Million) Table 30. Global Emerging Cancer Vaccines Revenue by Type (2023-2028) & (US$ Million) Table 31. Global Emerging Cancer Vaccines Revenue Share by Type (2017-2022) Table 32. Global Emerging Cancer Vaccines Revenue Share by Type (2023-2028) Table 33. Emerging Cancer Vaccines Price by Type (2017-2022) & (USD/Unit) Table 34. Global Emerging Cancer Vaccines Price Forecast by Type (2023-2028) & (USD/Unit) Table 35. Global Emerging Cancer Vaccines Sales by Application (2017-2022) & (K Units) Table 36. Global Emerging Cancer Vaccines Sales by Application (2023-2028) & (K Units) Table 37. Global Emerging Cancer Vaccines Sales Share by Application (2017-2022) Table 38. Global Emerging Cancer Vaccines Sales Share by Application (2023-2028) Table 39. Global Emerging Cancer Vaccines Revenue by Application (2017-2022) & (US$ Million) Table 40. Global Emerging Cancer Vaccines Revenue by Application (2023-2028) & (US$ Million) Table 41. Global Emerging Cancer Vaccines Revenue Share by Application (2017-2022) Table 42. Global Emerging Cancer Vaccines Revenue Share by Application (2023-2028) Table 43. Emerging Cancer Vaccines Price by Application (2017-2022) & (USD/Unit) Table 44. Global Emerging Cancer Vaccines Price Forecast by Application (2023-2028) & (USD/Unit) Table 45. North America Emerging Cancer Vaccines Sales by Type (2017-2022) & (K Units) Table 46. North America Emerging Cancer Vaccines Sales by Type (2023-2028) & (K Units) Table 47. North America Emerging Cancer Vaccines Revenue by Type (2017-2022) & (US$ Million) Table 48. North America Emerging Cancer Vaccines Revenue by Type (2023-2028) & (US$ Million) Table 49. North America Emerging Cancer Vaccines Sales by Application (2017-2022) & (K Units) Table 50. North America Emerging Cancer Vaccines Sales by Application (2023-2028) & (K Units) Table 51. North America Emerging Cancer Vaccines Revenue by Application (2017-2022) & (US$ Million) Table 52. North America Emerging Cancer Vaccines Revenue by Application (2023-2028) & (US$ Million) Table 53. North America Emerging Cancer Vaccines Sales by Country (2017-2022) & (K Units) Table 54. North America Emerging Cancer Vaccines Sales by Country (2023-2028) & (K Units) Table 55. North America Emerging Cancer Vaccines Revenue by Country (2017-2022) & (US$ Million) Table 56. North America Emerging Cancer Vaccines Revenue by Country (2023-2028) & (US$ Million) Table 57. Europe Emerging Cancer Vaccines Sales by Type (2017-2022) & (K Units) Table 58. Europe Emerging Cancer Vaccines Sales by Type (2023-2028) & (K Units) Table 59. Europe Emerging Cancer Vaccines Revenue by Type (2017-2022) & (US$ Million) Table 60. Europe Emerging Cancer Vaccines Revenue by Type (2023-2028) & (US$ Million) Table 61. Europe Emerging Cancer Vaccines Sales by Application (2017-2022) & (K Units) Table 62. Europe Emerging Cancer Vaccines Sales by Application (2023-2028) & (K Units) Table 63. Europe Emerging Cancer Vaccines Revenue by Application (2017-2022) & (US$ Million) Table 64. Europe Emerging Cancer Vaccines Revenue by Application (2023-2028) & (US$ Million) Table 65. Europe Emerging Cancer Vaccines Sales by Country (2017-2022) & (K Units) Table 66. Europe Emerging Cancer Vaccines Sales by Country (2023-2028) & (K Units) Table 67. Europe Emerging Cancer Vaccines Revenue by Country (2017-2022) & (US$ Million) Table 68. Europe Emerging Cancer Vaccines Revenue by Country (2023-2028) & (US$ Million) Table 69. Asia Pacific Emerging Cancer Vaccines Sales by Type (2017-2022) & (K Units) Table 70. Asia Pacific Emerging Cancer Vaccines Sales by Type (2023-2028) & (K Units) Table 71. Asia Pacific Emerging Cancer Vaccines Revenue by Type (2017-2022) & (US$ Million) Table 72. Asia Pacific Emerging Cancer Vaccines Revenue by Type (2023-2028) & (US$ Million) Table 73. Asia Pacific Emerging Cancer Vaccines Sales by Application (2017-2022) & (K Units) Table 74. Asia Pacific Emerging Cancer Vaccines Sales by Application (2023-2028) & (K Units) Table 75. Asia Pacific Emerging Cancer Vaccines Revenue by Application (2017-2022) & (US$ Million) Table 76. Asia Pacific Emerging Cancer Vaccines Revenue by Application (2023-2028) & (US$ Million) Table 77. Asia Pacific Emerging Cancer Vaccines Sales by Region (2017-2022) & (K Units) Table 78. Asia Pacific Emerging Cancer Vaccines Sales by Region (2023-2028) & (K Units) Table 79. Asia Pacific Emerging Cancer Vaccines Revenue by Region (2017-2022) & (US$ Million) Table 80. Asia Pacific Emerging Cancer Vaccines Revenue by Region (2023-2028) & (US$ Million) Table 81. Latin America Emerging Cancer Vaccines Sales by Type (2017-2022) & (K Units) Table 82. Latin America Emerging Cancer Vaccines Sales by Type (2023-2028) & (K Units) Table 83. Latin America Emerging Cancer Vaccines Revenue by Type (2017-2022) & (US$ Million) Table 84. Latin America Emerging Cancer Vaccines Revenue by Type (2023-2028) & (US$ Million) Table 85. Latin America Emerging Cancer Vaccines Sales by Application (2017-2022) & (K Units) Table 86. Latin America Emerging Cancer Vaccines Sales by Application (2023-2028) & (K Units) Table 87. Latin America Emerging Cancer Vaccines Revenue by Application (2017-2022) & (US$ Million) Table 88. Latin America Emerging Cancer Vaccines Revenue by Application (2023-2028) & (US$ Million) Table 89. Latin America Emerging Cancer Vaccines Sales by Country (2017-2022) & (K Units) Table 90. Latin America Emerging Cancer Vaccines Sales by Country (2023-2028) & (K Units) Table 91. Latin America Emerging Cancer Vaccines Revenue by Country (2017-2022) & (US$ Million) Table 92. Latin America Emerging Cancer Vaccines Revenue by Country (2023-2028) & (US$ Million) Table 93. Middle East and Africa Emerging Cancer Vaccines Sales by Type (2017-2022) & (K Units) Table 94. Middle East and Africa Emerging Cancer Vaccines Sales by Type (2023-2028) & (K Units) Table 95. Middle East and Africa Emerging Cancer Vaccines Revenue by Type (2017-2022) & (US$ Million) Table 96. Middle East and Africa Emerging Cancer Vaccines Revenue by Type (2023-2028) & (US$ Million) Table 97. Middle East and Africa Emerging Cancer Vaccines Sales by Application (2017-2022) & (K Units) Table 98. Middle East and Africa Emerging Cancer Vaccines Sales by Application (2023-2028) & (K Units) Table 99. Middle East and Africa Emerging Cancer Vaccines Revenue by Application (2017-2022) & (US$ Million) Table 100. Middle East and Africa Emerging Cancer Vaccines Revenue by Application (2023-2028) & (US$ Million) Table 101. Middle East and Africa Emerging Cancer Vaccines Sales by Country (2017-2022) & (K Units) Table 102. Middle East and Africa Emerging Cancer Vaccines Sales by Country (2023-2028) & (K Units) Table 103. Middle East and Africa Emerging Cancer Vaccines Revenue by Country (2017-2022) & (US$ Million) Table 104. Middle East and Africa Emerging Cancer Vaccines Revenue by Country (2023-2028) & (US$ Million) Table 105. Antigenics Corporation Information Table 106. Antigenics Description and Major Businesses Table 107. Antigenics Emerging Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 108. Antigenics Emerging Cancer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications Table 109. Antigenics Recent Developments Table 110. Avax Technologies Corporation Information Table 111. Avax Technologies Description and Major Businesses Table 112. Avax Technologies Emerging Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 113. Avax Technologies Emerging Cancer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications Table 114. Avax Technologies Recent Developments Table 115. GlaxoSmithKline Corporation Information Table 116. GlaxoSmithKline Description and Major Businesses Table 117. GlaxoSmithKline Emerging Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 118. GlaxoSmithKline Emerging Cancer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications Table 119. GlaxoSmithKline Recent Developments Table 120. Merck Corporation Information Table 121. Merck Description and Major Businesses Table 122. Merck Emerging Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 123. Merck Emerging Cancer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications Table 124. Merck Recent Developments Table 125. Moderna Corporation Information Table 126. Moderna Description and Major Businesses Table 127. Moderna Emerging Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 128. Moderna Emerging Cancer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications Table 129. Moderna Recent Developments Table 130. Northwest Biotherapeutics Corporation Information Table 131. Northwest Biotherapeutics Description and Major Businesses Table 132. Northwest Biotherapeutics Emerging Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 133. Northwest Biotherapeutics Emerging Cancer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications Table 134. Northwest Biotherapeutics Recent Developments Table 135. Key Raw Materials Lists Table 136. Raw Materials Key Suppliers Lists Table 137. Emerging Cancer Vaccines Distributors List Table 138. Emerging Cancer Vaccines Customers List Table 139. Emerging Cancer Vaccines Market Trends Table 140. Emerging Cancer Vaccines Market Drivers Table 141. Emerging Cancer Vaccines Market Challenges Table 142. Emerging Cancer Vaccines Market Restraints Table 143. Research Programs/Design for This Report Table 144. Key Data Information from Secondary Sources Table 145. Key Data Information from Primary Sources List of Figures Figure 1. Emerging Cancer Vaccines Product Picture Figure 3. Global Emerging Cancer Vaccines Market Share by Type in 2021 & 2028 Figure 3. Non Genetic Vaccines Product Picture Figure 4. Genetic Vaccines Product Picture Figure 5. Global Emerging Cancer Vaccines Market Share by Application in 2021 & 2028 Figure 6. Cancer Research Centers Figure 7. Cancer Hospital Figure 8. Clinics Figure 9. Others Figure 10. Emerging Cancer Vaccines Report Years Considered Figure 11. Global Emerging Cancer Vaccines Sales 2017-2028 (K Units) Figure 12. Global Emerging Cancer Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Emerging Cancer Vaccines Revenue 2017-2028 (US$ Million) Figure 14. Global Emerging Cancer Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 15. Global Emerging Cancer Vaccines Sales Market Share by Region (2017-2022) Figure 16. Global Emerging Cancer Vaccines Sales Market Share by Region (2023-2028) Figure 17. North America Emerging Cancer Vaccines Sales YoY (2017-2028) & (K Units) Figure 18. North America Emerging Cancer Vaccines Revenue YoY (2017-2028) & (US$ Million) Figure 19. Europe Emerging Cancer Vaccines Sales YoY (2017-2028) & (K Units) Figure 20. Europe Emerging Cancer Vaccines Revenue YoY (2017-2028) & (US$ Million) Figure 21. Asia-Pacific Emerging Cancer Vaccines Sales YoY (2017-2028) & (K Units) Figure 22. Asia-Pacific Emerging Cancer Vaccines Revenue YoY (2017-2028) & (US$ Million) Figure 23. Latin America Emerging Cancer Vaccines Sales YoY (2017-2028) & (K Units) Figure 24. Latin America Emerging Cancer Vaccines Revenue YoY (2017-2028) & (US$ Million) Figure 25. Middle East & Africa Emerging Cancer Vaccines Sales YoY (2017-2028) & (K Units) Figure 26. Middle East & Africa Emerging Cancer Vaccines Revenue YoY (2017-2028) & (US$ Million) Figure 27. The Emerging Cancer Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 28. The Top 5 and 10 Largest Manufacturers of Emerging Cancer Vaccines in the World: Market Share by Emerging Cancer Vaccines Revenue in 2021 Figure 29. Global Emerging Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 30. Global Emerging Cancer Vaccines Sales Market Share by Type (2017-2028) Figure 31. Global Emerging Cancer Vaccines Revenue Market Share by Type (2017-2028) Figure 32. Global Emerging Cancer Vaccines Sales Market Share by Application (2017-2028) Figure 33. Global Emerging Cancer Vaccines Revenue Market Share by Application (2017-2028) Figure 34. North America Emerging Cancer Vaccines Sales Market Share by Type (2017-2028) Figure 35. North America Emerging Cancer Vaccines Revenue Market Share by Type (2017-2028) Figure 36. North America Emerging Cancer Vaccines Sales Market Share by Application (2017-2028) Figure 37. North America Emerging Cancer Vaccines Revenue Market Share by Application (2017-2028) Figure 38. North America Emerging Cancer Vaccines Sales Share by Country (2017-2028) Figure 39. North America Emerging Cancer Vaccines Revenue Share by Country (2017-2028) Figure 40. U.S. Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 41. Canada Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 42. Europe Emerging Cancer Vaccines Sales Market Share by Type (2017-2028) Figure 43. Europe Emerging Cancer Vaccines Revenue Market Share by Type (2017-2028) Figure 44. Europe Emerging Cancer Vaccines Sales Market Share by Application (2017-2028) Figure 45. Europe Emerging Cancer Vaccines Revenue Market Share by Application (2017-2028) Figure 46. Europe Emerging Cancer Vaccines Sales Share by Country (2017-2028) Figure 47. Europe Emerging Cancer Vaccines Revenue Share by Country (2017-2028) Figure 48. Germany Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 49. France Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 50. U.K. Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 51. Italy Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 52. Russia Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 53. Asia Pacific Emerging Cancer Vaccines Sales Market Share by Type (2017-2028) Figure 54. Asia Pacific Emerging Cancer Vaccines Revenue Market Share by Type (2017-2028) Figure 55. Asia Pacific Emerging Cancer Vaccines Sales Market Share by Application (2017-2028) Figure 56. Asia Pacific Emerging Cancer Vaccines Revenue Market Share by Application (2017-2028) Figure 57. Asia Pacific Emerging Cancer Vaccines Sales Share by Region (2017-2028) Figure 58. Asia Pacific Emerging Cancer Vaccines Revenue Share by Region (2017-2028) Figure 59. China Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 60. Japan Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 61. South Korea Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 62. India Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 63. Australia Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 64. Taiwan Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 65. Indonesia Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 66. Thailand Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 67. Malaysia Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 68. Philippines Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 69. Latin America Emerging Cancer Vaccines Sales Market Share by Type (2017-2028) Figure 70. Latin America Emerging Cancer Vaccines Revenue Market Share by Type (2017-2028) Figure 71. Latin America Emerging Cancer Vaccines Sales Market Share by Application (2017-2028) Figure 72. Latin America Emerging Cancer Vaccines Revenue Market Share by Application (2017-2028) Figure 73. Latin America Emerging Cancer Vaccines Sales Share by Country (2017-2028) Figure 74. Latin America Emerging Cancer Vaccines Revenue Share by Country (2017-2028) Figure 75. Mexico Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 76. Brazil Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 77. Argentina Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 78. Middle East and Africa Emerging Cancer Vaccines Sales Market Share by Type (2017-2028) Figure 79. Middle East and Africa Emerging Cancer Vaccines Revenue Market Share by Type (2017-2028) Figure 80. Middle East and Africa Emerging Cancer Vaccines Sales Market Share by Application (2017-2028) Figure 81. Middle East and Africa Emerging Cancer Vaccines Revenue Market Share by Application (2017-2028) Figure 82. Middle East and Africa Emerging Cancer Vaccines Sales Share by Country (2017-2028) Figure 83. Middle East and Africa Emerging Cancer Vaccines Revenue Share by Country (2017-2028) Figure 84. Turkey Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 85. Saudi Arabia Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 86. U.A.E Emerging Cancer Vaccines Revenue (2017-2028) & (US$ Million) Figure 87. Emerging Cancer Vaccines Value Chain Figure 88. Emerging Cancer Vaccines Production Process Figure 89. Channels of Distribution Figure 90. Distributors Profiles Figure 91. Bottom-up and Top-down Approaches for This Report Figure 92. Data Triangulation Figure 93. Key Executives Interviewed

Antigenics Avax Technologies GlaxoSmithKline Merck Moderna Northwest Biotherapeutics